The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes
Open accessAbstract
The emergence of carbapenem resistance in Enterobacteriaceae is an important threat to global health. Reported outcomes of infections with carbapenem-resistant Enterobacteriaceae (CRE) are poor. Very few options remain for the treatment of these virulent organisms. Antibiotics which are currently in use to treat CRE infections include aminoglycosides, polymyxins, tigecycline, fosfomycin, and temocillin. In addition, the role of combination therapy, including carbapenem containing regimens, remains to be defined. There are several important concerns regarding all of these treatment options such as limited efficacy, increasing reports of resistance, and specific toxicities. Data from retrospective studies favor combination therapy over single-agent therapy for the treatment of CRE bloodstream infections. In summary, new antibiotics are greatly needed, as is additional prospective research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Falagas, M. E., Kasiakou, S. K., & Saravolatz, L. D. (2005) · Clinical Infectious Diseases · doi:10.1086/429323 · Cited by 1,744
Moore, R. D., Lietman, P. S., & Smith, C. R. (1987) · Journal of Infectious Diseases · doi:10.1093/infdis/155.1.93 · Cited by 1,139
Tumbarello, M., Viale, P., Viscoli, C., Trecarichi, E. M., Tumietto, F., Marchese, A., Spanu, T., Ambretti, S., Ginocchio, F., Cristini, F., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis588 · Cited by 1,016
Health Care Costs and Mortality Associated with Nosocomial Diarrhea Due to Clostridium difficile
Kyne, L., Hamel, M. B., Polavaram, R., & Kelly, C. P. (2002) · Clinical Infectious Diseases · doi:10.1086/338260 · Cited by 904
Combating Antimicrobial Resistance: Policy Recommendations to Save Lives
Infectious Diseases Society of America (IDSA) (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir153 · Cited by 733
Garonzik, S. M., Li, J., Thamlikitkul, V., Paterson, D. L., Shoham, S., Jacob, J., Silveira, F. P., Forrest, A., & Nation, R. L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01733-10 · Cited by 696
Bratu, S., Landman, D., Haag, R., Recco, R., Eramo, A., Alam, M., & Quale, J. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.12.1430 · Cited by 573
Qureshi, Z. A., Paterson, D. L., Potoski, B. A., Kilayko, M. C., Sandovsky, G., Sordillo, E., Polsky, B., Adams-Haduch, J. M., & Doi, Y. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06268-11 · Cited by 559
Safdar, N., & Maki, D. G. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-11-200206040-00013 · Cited by 556
Hirsch, E. B., & Tam, V. H. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq108 · Cited by 477
Zarkotou, O., Pournaras, S., Tselioti, P., Dragoumanos, V., Pitiriga, V., Ranellou, K., Prekates, A., Themeli-Digalaki, K., & Tsakris, A. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03514.x · Cited by 438
Attributable Mortality Rate for Carbapenem-Resistant Klebsiella pneumoniae Bacteremia
Borer, A., Saidel-Odes, L., Riesenberg, K., Eskira, S., Peled, N., Nativ, R., Schlaeffer, F., & Sherf, M. (2009) · Infection Control & Hospital Epidemiology · doi:10.1086/605922 · Cited by 389
Michalopoulos, A. S., Livaditis, I. G., & Gougoutas, V. (2011) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2011.07.007 · Cited by 378
Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections
Ben-David, D., Kordevani, R., Keller, N., Tal, I., Marzel, A., Gal-Mor, O., Maor, Y., & Rahav, G. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03478.x · Cited by 353
Livermore, D. M., Warner, M., Mushtaq, S., Doumith, M., Zhang, J., & Woodford, N. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.01.012 · Cited by 341
Pogue, J. M., Lee, J., Marchaim, D., Yee, V., Zhao, J. J., Chopra, T., Lephart, P., & Kaye, K. S. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir611 · Cited by 327
Self-citationCombination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary
Chow, J. W., & Yu, V. L. (1999) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(98)00060-0 · Cited by 320
Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose
Rodvold, K. A., Gotfried, M. H., Cwik, M., Korth-Bradley, J. M., Dukart, G., & Ellis-Grosse, E. J. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl403 · Cited by 304
Excess Deaths Associated With Tigecycline After Approval Based on Noninferiority Trials
Prasad, P., Sun, J., Danner, R. L., & Natanson, C. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis270 · Cited by 298
Souli, M., Galani, I., Antoniadou, A., Papadomichelakis, E., Poulakou, G., Panagea, T., Vourli, S., Zerva, L., Armaganidis, A., Kanellakopoulou, K., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/649865 · Cited by 271
Efficacy and safety of tigecycline: a systematic review and meta-analysis
Yahav, D., Lador, A., Paul, M., & Leibovici, L. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr242 · Cited by 266
Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis
Tasina, E., Haidich, A.-B., Kokkali, S., & Arvanitidou, M. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70177-3 · Cited by 260
Linden, P. K., Kusne, S., Coley, K., Fontes, P., Kramer, D. J., & Paterson, D. (2003) · Clinical Infectious Diseases · doi:10.1086/379611 · Cited by 252
Dalfino, L., Puntillo, F., Mosca, A., Monno, R., Spada, M. L., Coppolecchia, S., Miragliotta, G., Bruno, F., & Brienza, N. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis286 · Cited by 247
Martindale: The Complete Drug Reference. 37th ed
Wisher, D. (2012) · Journal of the Medical Library Association : JMLA · doi:10.3163/1536-5050.100.1.018 · Cited by 246
Won, S. Y., Munoz-Price, L. S., Lolans, K., Hota, B., Weinstein, R. A., Hayden, M. K., & Program, F. T. C. F. D. C. A. P. E. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir482 · Cited by 240
Daikos, G. L., & Markogiannakis, A. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03553.x · Cited by 238
Karageorgopoulos, D. E., Wang, R., Yu, X.-H., & Falagas, M. E. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr466 · Cited by 228
Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria
Falagas, M. E., Bliziotis, I. A., Kasiakou, S. K., Samonis, G., Athanassopoulou, P., & Michalopoulos, A. (2005) · BMC Infectious Diseases · doi:10.1186/1471-2334-5-24 · Cited by 224
Daikos, G. L., Petrikkos, P., Psichogiou, M., Kosmidis, C., Vryonis, E., Skoutelis, A., Georgousi, K., Tzouvelekis, L. S., Tassios, P. T., Bamia, C., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00782-08 · Cited by 210
Dudhani, R. V., Turnidge, J. D., Coulthard, K., Milne, R. W., Rayner, C. R., Li, J., & Nation, R. L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01114-09 · Cited by 205
Pharmacodynamics of Polymyxin B against Pseudomonas aeruginosa
Tam, V. H., Schilling, A. N., Vo, G., Kabbara, S., Kwa, A. L., Wiederhold, N. P., & Lewis, R. E. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3624-3630.2005 · Cited by 204
Double-Carbapenem Therapy for Carbapenemase-Producing Klebsiella pneumoniae
Bulik, C. C., & Nicolau, D. P. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01420-10 · Cited by 200
Rhomberg, P. R., & Jones, R. N. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.08.020 · Cited by 195
Perez, F., Endimiani, A., Ray, A. J., Decker, B. K., Wallace, C. J., Hujer, K. M., Ecker, D. J., Adams, M. D., Toltzis, P., Dul, M. J., et al. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq191 · Cited by 194
Self-citationCai, Y., Wang, R., Liang, B., Bai, N., & Liu, Y. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01402-10 · Cited by 189
Ouderkirk, J. P., Nord, J. A., Turett, G. S., & Kislak, J. W. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2659-2662.2003 · Cited by 188
Mouloudi, E. K., Protonotariou, E., Zagorianou, A., Iosifidis, Ε., Karapanagiotou, A., Giasnetsova, T., Tsioka, A., Roilides, E., Sofianou, D., & Gritsi-Gerogianni, N. (2010) · Infection Control and Hospital Epidemiology · doi:10.1086/657135 · Cited by 171
Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections
Neuner, E. A., Yeh, J.-Y., Hall, G. S., Sekeres, J., Endimiani, A., Bonomo, R. A., Shrestha, N. K., Fraser, T. G., & van Duin, D. (2011) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.10.013 · Cited by 166
Self-citationYousef, J. M., Chen, G., Hill, P., Nation, R. L., & Li, J. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr483 · Cited by 160
Edson, R. S., & Terrell, C. L. (1999) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)65134-3 · Cited by 153
Pharmacokinetic/pharmacodynamic profile for tigecycline—a new glycylcycline antimicrobial agent
Meagher, A. K., Ambrose, P. G., Grasela, T. H., & Ellis‐Grosse, E. J. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.05.006 · Cited by 138
Millam, S. (2006) · Humana Press eBooks · doi:10.1385/1-59745-131-2:25 · Cited by 132
Satlin, M. J., Kubin, C. J., Blumenthal, J. S., Cohen, A. B., Furuya, E. Y., Wilson, S. J., Jenkins, S. G., & Calfee, D. P. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00387-11 · Cited by 132
Melatonin Attenuates Colistin-Induced Nephrotoxicity in Rats
Yousef, J. M., Chen, G., Hill, P., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00328-11 · Cited by 132
Combating Antimicrobial Resistance: Policy Recommendations to Save Lives
(2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir154 · Cited by 125
Endimiani, A., Hujer, K. M., Hujer, A. M., Armstrong, E. S., Choudhary, Y., Aggen, J. B., & Bonomo, R. A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00556-09 · Cited by 118
Self-citationRecent trends in antibiotic resistance in European ICUs
van Duijn, P. J., Dautzenberg, M. J. D., & Oostdijk, E. A. N. (2011) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32834c9d87 · Cited by 112
Colistin pharmacokinetics: the fog is lifting
Couet, W. R., Grégoire, N., Marchand, S., & Mimoz, O. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03667.x · Cited by 111
Trends in antimicrobial resistance in intensive care units in the United States
Prabaker, K. K., & Weinstein, R. A. (2011) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32834a4b03 · Cited by 99
Holloway, K. P., Rouphael, N., Wells, J. B., King, M. D., & Blumberg, H. M. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1h353 · Cited by 84
Ku, K. P., Pogue, J. M., Moshos, J. A., Bheemreddy, S., Wang, Y., Bhargava, A., Campbell, M., Khandker, N., Lephart, P., Chopra, T., et al. (2012) · American Journal of Infection Control · doi:10.1016/j.ajic.2011.12.014 · Cited by 78
Self-citationMarchaim, D., Chopra, T., Pérez, F., Hayakawa, K., Lephart, P., Bheemreddy, S., Blunden, C. E., Hujer, A. M., Rudin, S. D., Shango, M. M., et al. (2011) · Infection Control and Hospital Epidemiology · doi:10.1086/661597 · Cited by 67
Self-citationAlexander, B. T., Marschall, J., Tibbetts, R. J., Neuner, E. A., Dunne, W. M., & Ritchie, D. J. (2012) · Clinical Therapeutics · doi:10.1016/j.clinthera.2012.05.002 · Cited by 60
Self-citationJin, Z., Yang, Y., Choi, J. Y., Shinde, P., Yoon, S. Y., Hahn, T., Lim, H. T., Park, Y., Hahm, K. S., Joo, J. W., et al. (2008) · Journal of Animal Science · doi:10.2527/jas.2007-0414 · Cited by 58
Huttner, B. D., Jones, M., Rubin, M. A., Neuhauser, M. M., Gundlapalli, A. V., & Samore, M. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036649 · Cited by 42
Lautenbach, E., Han, J., Santana, E., Tolomeo, P., Bilker, W. B., & Maslow, J. N. (2012) · Infection Control and Hospital Epidemiology · doi:10.1086/664055 · Cited by 29
Cited by
The global epidemiology of carbapenemase-producing Enterobacteriaceae
van Duin, D., & Doi, Y. (2017) · Virulence · doi:10.1080/21505594.2016.1222343 · Cited by 1,004
Self-citationEpidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria
Nordmann, P., & Poirel, L. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz824 · Cited by 721
van Duin, D., Lok, J. J., Earley, M., Cober, E., Richter, S. S., Perez, F., Salata, R. A., Kalayjian, R. C., Watkins, R. R., Doi, Y., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix783 · Cited by 655
Self-citationMultidrug-Resistant Bacteria in the Community
van Duin, D., & Paterson, D. L. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2016.02.004 · Cited by 584
Self-citationvan Duin, D., & Bonomo, R. A. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw243 · Cited by 549
Self-citation
Metadata
- Authors
- van Duin, D., Kaye, K. S., Neuner, E. A., & Bonomo, R. A.
- Venue
- Diagnostic Microbiology and Infectious Disease
- Publisher
- Elsevier BV
- Published
- 2013-02
- Volume
- 75
- Issue
- 2
- Pages
- 115-120
- ISSN
- 0732-8893 (ISSN-L)
- OpenAlex
- W2021439166
- Cited by
- 352
- References
- 57
- FWCI
- 13.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.